Prostate Cancer News and Features TOC

Tools & Resources

News and FeaturesRelated to Prostate Cancer

Finger Length a Clue to Prostate Cancer Risk

Dec. 1, 2010 -- Men whose index finger is longer than their ring finger are at a lower risk of prostate cancer than those with a finger pattern the other way round, according to a new study in the British Journal of Cancer . The relative length of the first and third fingers is set before birth, and
Read Full Article
Prostate Cancer: Active Surveillance Offers Quality-of-Life Gains

Nov. 30, 2010 -- Active surveillance for men with localized prostate cancer may offer up some important quality-of-life advantages when compared to other initial prostate cancer treatments, such as radiation therapy and surgical removal of the prostate gland (radical prostatectomy), according to a n
Read Full Article
Prostate Cancer Staging Can't Predict Recurrence

Nov. 22, 2010 -- One of the first things that a man wants to know after he has been diagnosed with prostate cancer is the cancer’s stage, which is supposed to indicate the extent of the disease and help predict the likelihood of recurrence after treatment. But when it comes to localized or non-sprea
Read Full Article
Targeted Radiation May Help Men Avoid Impotence

Nov. 5, 2010 -- A highly targeted form of radiation therapy may help younger men to avoid becoming impotent after treatment for prostate cancer, a preliminary study of nearly 100 men aged 55 and younger suggests. Six months after undergoing proton therapy, 90% of participants who had been sexually a
Read Full Article
Aspirin May Cut Prostate Cancer Deaths

Oct. 25, 2010 -- Aspirin, already linked in some studies to a lower risk of developing colon cancer, may also cut the risk of dying of prostate cancer by more than half, a large study suggests. Researchers stress the findings are preliminary and that men with the cancer should not reach for the aspi
Read Full Article
PSA Tests Cut Risk of Prostate Cancer Spread

Oct. 25, 2010 -- Routine PSA testing substantially lowers the chance that prostate cancer will spread to other parts of the body, researchers report. Once the disease spreads, it is no longer curable, says study head Chandana Reddy, MS, a senior biostatistician at the Cleveland Clinic. Additionally,
Read Full Article
Drug Extends Prostate Cancer Survival

Oct. 12, 2010 -- Even when medical or surgical castration fails, a potent drug extends survival by four months in patients with metastatic prostate cancer. The drug is Johnson & Johnson's abiraterone acetate. It blocks an enzyme crucial to the production of male hormones, which spur the growth and s
Read Full Article
PSA Tests for Prostate Cancer May Not Save Lives

Sept. 14, 2010 - Routine PSA screening tests for prostate cancer don't save lives. That's the bottom line from a painstaking analysis of major clinical trials by University of Florida researcher Philipp Dahm, MD, and colleagues. They reviewed data on 387,286 men enrolled in six large clinical trials
Read Full Article
Aggressive Treatment for Prostate Cancer Is the Norm

July 26, 2010 -- More than 75% of men diagnosed with low-risk prostate cancer undergo aggressive treatment -- either complete removal of the prostate or radiation therapy, according to a new study. That's true, the researchers found, even in men with a low level of prostate-specific antigen (PSA) of
Read Full Article
Prostate Cancer Screening: Benefits Outweigh Risks

July 1, 2010 -- Screening men for prostate cancer cut mortality rates by about half in a large study, researchers report. The screening test under investigation is called a prostate-specific antigen (PSA) test, which measures blood levels of a protein produced by prostate gland cells and is a marker
Read Full Article